Maybelline Eyebrow Pomade – 24-Hour Waterproof Definition

Product Description

Maybelline Eyebrow Pomade – 24-Hour Waterproof Definition is a premium eyebrow product designed to deliver long-lasting definition and shape to your brows. Featuring a temporary tattoo effect, this pomade provides 24-hour waterproof wear, making it ideal for daily use and ensuring your brows remain beautifully defined throughout the day. Its user-friendly formula allows for easy application, while its waterproof and transfer-resistant qualities ensure that your brows stay looking perfect regardless of the conditions.

Key Benefits/ Features:

Long-lasting Wear

The Maybelline Eyebrow Pomade offers a remarkable 24-hour hold, ensuring that your brows remain perfectly defined from morning to night. This extended wear time makes it suitable for those who require reliable performance throughout the day.

Waterproof and Transfer-resistant

This pomade is engineered to withstand water and prevent transfer, allowing you to maintain your brow look in various situations. Whether facing humidity or sweat, this product ensures your brows stay intact.

Easy Application

The pomade’s smooth texture allows for effortless application, making it suitable for both experienced users and those new to eyebrow enhancement. The formula glides on easily, providing the opportunity for quick touch-ups or precise shaping.

Dual-sided Brush

Included with the pomade is a dual-sided brush that assists in shaping and defining your brows. This tool enhances the ease of application, allowing for a natural finish that can be customized to your preference.

Consumer Tested

The effectiveness of this product is backed by consumer testing, with 91 women validating the reliability of its 24-hour wear and waterproof capabilities. This real-world evidence underlines the product’s performance and suitability for various lifestyles.

Product Details:

– Type: Eyebrow Pomade
– Wear: 24-hour waterproof
– Features: Transfer-resistant, dual-sided brush included
– Testing: Consumer tested (91 women)